Antonio Bonfiglio, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000 |
Heaveen Ahdi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001 |
Jim Getzinger, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Ec, Royal Oak, MI 48073 Phone: 248-898-5000 |
Charlene Irvin Babcock, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Ste. Ec, Royal Oak, MI 48073 Phone: 248-898-0575 Fax: 248-898-4671 |
Jacob Price, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001 |
Deborah Trimble, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 504-655-4252 |
Julian Sit, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W Thirteen Mile Rd., Royal Oak, MI 48073 Phone: 248-898-2001 |
Dr. Ann Dally, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001 |
Nivetha Sankarappa Kumar, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3601 W Thirteen Mile Rd, Attn: Emergency Medicine, Royal Oak, MI 48073 Phone: 248-898-2001 |
Lynn Frikker, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Ec, Royal Oak, MI 48073 Phone: 248-898-2015 |
Dr. Patrick Thul Pettengill, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-0575 Fax: 248-898-4671 |
David Buether, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001 |
Jeffrey S Ditkoff, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-0424 Fax: 248-551-5426 |
Brenda Sue Donaldson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Fsc, Royal Oak, MI 48073 Phone: 248-423-2454 Fax: 248-423-2576 |
Dr. Kelsea Meghan Flanagan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-0424 |
Dr. Aakash Naik, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000 |
Sydney Miller, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-0727 |
Kyle Hammermeister, M.D. Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001 |
Kelly Sawyer, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Beaumont Hospital - Royal Oak, Royal Oak, MI 48073 Phone: 248-898-0575 |
Sagar Shailesh Shah, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001 |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the pathology community, today introduced AP Anywhere, its bundled Anatomic Pathology Laboratory Information System technology offering.
Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31).
Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 10-4 that the response rate and duration of response observed with FOLOTYNTM (pralatrexate) are reasonably likely to predict clinical benefit in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
"The results of our study are very promising. Similar studies have demonstrated much smaller benefits for bone than we found. However, calcium and vitamin D deficiencies, which are present in half of older adults, may have prevented DHEA from improving bone density in the earlier studies," said Edward Weiss, Ph.D., associate professor of nutrition and dietetics at Saint Louis University's Doisy College of Health Sciences and lead author of the study.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
› Verified 3 days ago